STOCK TITAN

[Form 4] Canopy Growth Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Canopy Growth Corp director and Chief Legal Officer & Corporate Secretary Christelle Gedeon reported a sale of 16,929 common shares on 08/22/2025 at a price of CAD $1.74 per share. The filing states the disposition was made to satisfy tax obligations tied to the vesting of restricted stock units. After the sale, the reporting person beneficially owned 368,488 common shares. The Form 4 was signed by an attorney-in-fact on 08/26/2025. All amounts and the sale rationale are presented in the filing; no additional transaction types or derivative holdings are disclosed.

Christelle Gedeon, direttore e Chief Legal Officer & Corporate Secretary di Canopy Growth Corp, ha segnalato la vendita di 16.929 azioni ordinarie il 22/08/2025 a CAD $1,74 per azione. La comunicazione indica che la cessione è avvenuta per coprire le imposte dovute al vesting di restricted stock units. Dopo la vendita, la persona segnalante deteneva beneficiariamente 368.488 azioni ordinarie. Il Form 4 è stato firmato da un procuratore il 26/08/2025. Nel filing sono riportati tutti gli importi e le motivazioni della vendita; non vengono dichiarati altri tipi di operazioni né posizioni in derivati.

Christelle Gedeon, directora y Chief Legal Officer & Corporate Secretary de Canopy Growth Corp, informó la venta de 16.929 acciones ordinarias el 22/08/2025 a CAD $1,74 por acción. El informe indica que la disposición se efectuó para cumplir obligaciones fiscales vinculadas al vesting de restricted stock units. Tras la venta, la persona informante poseía beneficiariamente 368.488 acciones ordinarias. El Formulario 4 fue firmado por un apoderado el 26/08/2025. En la presentación se detallan todos los importes y la razón de la venta; no se declaran otros tipos de transacciones ni posiciones en derivados.

Canopy Growth Corp의 이사이자 Chief Legal Officer & Corporate Secretary인 Christelle Gedeon은 2025-08-2216,929 보통주를 주당 CAD $1.74에 매도했다고 보고했습니다. 신고서에 따르면 이번 처분은 제한주식유닛(restricted stock units)의 베스팅과 관련된 세금 의무를 충당하기 위한 것이었습니다. 매도 후 신고인은 368,488 보통주를 실질적으로 보유하고 있었습니다. Form 4는 2025-08-26에 대리인이 서명했습니다. 모든 금액과 매도 사유는 신고서에 기재되어 있으며 추가 거래 유형이나 파생상품 보유는 공개되지 않았습니다.

Christelle Gedeon, administratrice et Chief Legal Officer & Corporate Secretary de Canopy Growth Corp, a déclaré la vente de 16 929 actions ordinaires le 22/08/2025 au prix de CAD $1,74 par action. Le dépôt indique que la cession a été réalisée pour satisfaire des obligations fiscales liées au vesting de restricted stock units. Après la vente, la personne déclarante détenait effectivement 368 488 actions ordinaires. Le formulaire 4 a été signé par un mandataire le 26/08/2025. Tous les montants et le motif de la vente sont présentés dans le dépôt ; aucune autre catégorie de transaction ni position en dérivés n’est divulguée.

Christelle Gedeon, Direktorin sowie Chief Legal Officer & Corporate Secretary von Canopy Growth Corp, meldete den Verkauf von 16.929 Stammaktien am 22.08.2025 zu einem Preis von CAD $1,74 je Aktie. Die Einreichung gibt an, dass die Veräußerung zur Begleichung steuerlicher Verpflichtungen aus dem Vesting von Restricted Stock Units erfolgte. Nach dem Verkauf hielt die meldende Person wirtschaftlich 368.488 Stammaktien. Das Formular 4 wurde am 26.08.2025 von einem Bevollmächtigten unterzeichnet. Alle Beträge und der Verkaufsgrund sind in der Meldung angegeben; weitere Transaktionsarten oder Derivatbestände werden nicht offengelegt.

Positive
  • None.
Negative
  • Reporting person disposed of 16,929 shares, reducing immediate insider holdings; sale could be perceived negatively by some investors despite stated tax purpose

Insights

TL;DR: Insiders sold a small block of shares to cover taxes after RSU vesting; remaining ownership remains material.

The reported sale of 16,929 shares at CAD $1.74 is explicitly tied to tax obligations from RSU vesting, which is a common, non-operational reason for insider selling. The post-transaction beneficial ownership of 368,488 shares is disclosed, allowing investors to track insider stake but the filing provides no indication of operational or strategic changes at the company.

TL;DR: Transaction appears routine and compliance-driven; disclosure is timely and includes required detail.

The Form 4 identifies the reporting person, relationship to the issuer, exact share amounts, sale price in Canadian dollars, and a stated explanation that the sale satisfied tax obligations from RSU vesting. The signature by an attorney-in-fact is included. From a governance perspective, the filing meets Section 16 disclosure norms and contains no additional governance concerns.

Christelle Gedeon, direttore e Chief Legal Officer & Corporate Secretary di Canopy Growth Corp, ha segnalato la vendita di 16.929 azioni ordinarie il 22/08/2025 a CAD $1,74 per azione. La comunicazione indica che la cessione è avvenuta per coprire le imposte dovute al vesting di restricted stock units. Dopo la vendita, la persona segnalante deteneva beneficiariamente 368.488 azioni ordinarie. Il Form 4 è stato firmato da un procuratore il 26/08/2025. Nel filing sono riportati tutti gli importi e le motivazioni della vendita; non vengono dichiarati altri tipi di operazioni né posizioni in derivati.

Christelle Gedeon, directora y Chief Legal Officer & Corporate Secretary de Canopy Growth Corp, informó la venta de 16.929 acciones ordinarias el 22/08/2025 a CAD $1,74 por acción. El informe indica que la disposición se efectuó para cumplir obligaciones fiscales vinculadas al vesting de restricted stock units. Tras la venta, la persona informante poseía beneficiariamente 368.488 acciones ordinarias. El Formulario 4 fue firmado por un apoderado el 26/08/2025. En la presentación se detallan todos los importes y la razón de la venta; no se declaran otros tipos de transacciones ni posiciones en derivados.

Canopy Growth Corp의 이사이자 Chief Legal Officer & Corporate Secretary인 Christelle Gedeon은 2025-08-2216,929 보통주를 주당 CAD $1.74에 매도했다고 보고했습니다. 신고서에 따르면 이번 처분은 제한주식유닛(restricted stock units)의 베스팅과 관련된 세금 의무를 충당하기 위한 것이었습니다. 매도 후 신고인은 368,488 보통주를 실질적으로 보유하고 있었습니다. Form 4는 2025-08-26에 대리인이 서명했습니다. 모든 금액과 매도 사유는 신고서에 기재되어 있으며 추가 거래 유형이나 파생상품 보유는 공개되지 않았습니다.

Christelle Gedeon, administratrice et Chief Legal Officer & Corporate Secretary de Canopy Growth Corp, a déclaré la vente de 16 929 actions ordinaires le 22/08/2025 au prix de CAD $1,74 par action. Le dépôt indique que la cession a été réalisée pour satisfaire des obligations fiscales liées au vesting de restricted stock units. Après la vente, la personne déclarante détenait effectivement 368 488 actions ordinaires. Le formulaire 4 a été signé par un mandataire le 26/08/2025. Tous les montants et le motif de la vente sont présentés dans le dépôt ; aucune autre catégorie de transaction ni position en dérivés n’est divulguée.

Christelle Gedeon, Direktorin sowie Chief Legal Officer & Corporate Secretary von Canopy Growth Corp, meldete den Verkauf von 16.929 Stammaktien am 22.08.2025 zu einem Preis von CAD $1,74 je Aktie. Die Einreichung gibt an, dass die Veräußerung zur Begleichung steuerlicher Verpflichtungen aus dem Vesting von Restricted Stock Units erfolgte. Nach dem Verkauf hielt die meldende Person wirtschaftlich 368.488 Stammaktien. Das Formular 4 wurde am 26.08.2025 von einem Bevollmächtigten unterzeichnet. Alle Beträge und der Verkaufsgrund sind in der Meldung angegeben; weitere Transaktionsarten oder Derivatbestände werden nicht offengelegt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gedeon Christelle

(Last) (First) (Middle)
C/O CANOPY GROWTH CORPORATION
1 HERSHEY DRIVE

(Street)
SMITHS FALLS A6 K7A 0A8

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Canopy Growth Corp [ CGC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares 08/22/2025 S 16,929(1) D $1.74(2) 368,488 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of restricted stock units.
2. Price is expressed in Canadian dollars.
Remarks:
Chief Legal Officer and Corporate Secretary
/s/ Shai Marshall, Attorney-in-fact for Christelle Gedeon 08/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Canopy Growth insider file on Form 4 (CGC)?

The filing reports a sale of 16,929 common shares by Christelle Gedeon on 08/22/2025 at CAD $1.74 per share.

Why were the shares sold according to the Form 4?

The Form 4 states the disposition was made to satisfy tax obligations associated with the vesting of restricted stock units.

How many Canopy Growth shares does the reporting person own after the sale?

After the reported transaction the filing shows beneficial ownership of 368,488 common shares.

What is the reporting person’s role at Canopy Growth (CGC)?

The filing identifies the reporting person as a Director and as Chief Legal Officer and Corporate Secretary.

When was the Form 4 signed?

The signature block shows the Form 4 was signed by an attorney-in-fact on 08/26/2025.
Canopy Growth Corp

NASDAQ:CGC

CGC Rankings

CGC Latest News

CGC Latest SEC Filings

CGC Stock Data

345.38M
239.70M
0.06%
7.25%
13.63%
Drug Manufacturers - Specialty & Generic
Medicinal Chemicals & Botanical Products
Link
Canada
SMITH FALLS